Skip to main content
. 2023 Feb 21;24(4):e56524. doi: 10.15252/embr.202256524

Figure 7. PeSCs drive PD‐1 resistance in the tumor microenvironment.

Figure 7

  • A
    Experimental setting.
  • B–H
    (B) Tumor weight. FACS analysis of the percentage of CD45+ cells derived from the tumor (C), Ly6G+ MDSCs (D), F4/80+CD45+ cells (E), CD11c+CD45+ cells (F), CD4+CD45+ and IFNγ+CD4+ (G) and CD8+CD45+ and IFNγ+CD8+ (H). The results shown are cumulative from three independent experiments (each dot represents one mouse, 12–15 mice per group).
  • I
    Experimental setting.
  • J–O
    (J) Tumor weight. FACS analysis of CD44+PD‐1+Tim3+CD8+CD3+ T cells (K), CD107+CD8+ T cells (L), F4/80+CD163+ Macrophages (M), CD163+ Tim4+ Macrophages (N) and CD107+ Macrophages (O). The results shown are cumulative from three independent experiments (each dot represents one mouse, 9–12 mice per group).

Data information: *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. The P‐values were calculated using Student's t‐test.

Source data are available online for this figure.